Back
iShares LifePath Target Date 2040 ETF Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
ITDD
iShares LifePath Target Date 2040 ETF
Last Price:
$35.39
Seasonality Move:
2.42%
Buy
60
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$545.87
Seasonality Move:
13.5%
Buy
64
iShares LifePath Target Date 2040 ETF (ITDD)
is a Buy
Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?
-
The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.37. The Score for ITDD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
ITDD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $546.19. The Score for MDGL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITDD Stock Price Chart
What is iShares LifePath Target Date 2040 ETF's stock price today?
-
The iShares LifePath Target Date 2040 ETF share price today is $35.37The current trend is moderately bearish and ITDD is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $546.19The current trend is moderately bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
ITDD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 46.64 | Sell |
| Chaikin Money Flow: | -13204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.06 - 35.8) | Sell |
| Bollinger Bands (100): | (34.08 - 35.58) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.12 | Buy |
| Relative Strength Index (14 RSI): | 49.65 | Sell |
| Chaikin Money Flow: | -199987 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (541.81 - 584.93) | Sell |
| Bollinger Bands (100): | (377.57 - 529.47) | Buy |
ITDD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.67 | Sell |
| 20-day SMA: | 35.47 | Sell |
| 50-day SMA: | 35.39 | Sell |
| 200-day SMA: | 33.13 | Buy |
| 8-day EMA: | 35.61 | Sell |
| 20-day EMA: | 35.55 | Sell |
| 50-day EMA: | 35.31 | Buy |
| 200-day EMA: | 33.63 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 559.88 | Sell |
| 20-day SMA: | 569.93 | Sell |
| 50-day SMA: | 503.41 | Buy |
| 200-day SMA: | 380.65 | Buy |
| 8-day EMA: | 560.16 | Sell |
| 20-day EMA: | 555.94 | Sell |
| 50-day EMA: | 516.55 | Buy |
| 200-day EMA: | 408.33 | Buy |
iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.31 per share, and an increase next year of $15.02 per share.
iShares LifePath Target Date 2040 ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||